# PALM Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- The PALM gene encodes a phosphoprotein crucial for plasma membrane protrusion formation, cell shape regulation, and membrane trafficking, with significant expression in neurons where it influences dendritic spine morphology and synaptic plasticity.
- PALM's structure includes an N-terminal region with palmitoylation sites and polybasic domains for membrane interaction, a central coiled-coil domain for protein dimerization, and a C-terminal hydrophobic region for monotopic membrane anchoring.
- Dysregulation of PALM expression is linked to neuropsychiatric disorders like schizophrenia and bipolar disorder, and certain cancers, with specific SNPs in the PALM locus associated with reduced mRNA expression in the prefrontal cortex in schizophrenia.
- In breast cancer, elevated PALM expression correlates with poor prognosis and promotes cell migration and invasion via invadopodia formation, while in hepatocellular carcinoma, PALM is downregulated and acts as a tumor suppressor.
- While no direct drug targets exist, PALM's function can be modulated by inhibiting palmitoyl acyltransferases (e.g., 2-bromopalmitate) or protein kinase C, and gene therapy approaches are being explored for conditions of PALM underexpression or overexpression.
- PALM's role in membrane trafficking suggests potential indirect involvement in viral entry and replication pathways, though direct interactions with pathogens are not well-characterized.

---

## Executive Summary & Key Metadata

The paralemmin (PALM) gene encodes a phosphoprotein that is predominantly associated with the cytoplasmic face of the plasma membrane, where it participates in the formation and stabilization of membrane protrusions, cell shape control, and membrane trafficking dynamics. PALM is a member of the paralemmin family, which also includes paralemmin-2 (PALM2) and the related gene product PALMD (paralemmin-like). The protein is characterized by a conserved C-terminal hydrophobic region that mediates membrane anchoring, a central coiled-coil domain, and an N-terminal region that is subject to post-translational modification, particularly palmitoylation and phosphorylation. PALM is highly expressed in the brain, particularly in neurons, where it contributes to dendritic spine morphology and synaptic plasticity. It is also expressed in various peripheral tissues, including the adrenal gland, heart, and testis. The gene has been mapped to human chromosome 19p13.3, a region associated with several neurodevelopmental and psychiatric disorders. Alterations in PALM expression or function have been implicated in schizophrenia, bipolar disorder, and certain cancers, although the precise pathophysiological mechanisms remain under active investigation.

| **Metadata Field** | **Value** |
| --- | --- |
| **HGNC Symbol** | PALM |
| **UniProt Accession** | O75781 |
| **Representative PDB ID** | true (structural models available; see Section 2) |
| **Chromosomal Locus** | 19p13.3 (human); chromosome 10 (mouse) |
| **Primary Molecular Function** | Plasma membrane-associated phosphoprotein; regulation of membrane morphology, cell shape, and intracellular trafficking |
| **Disease & Pathology Associations** | Schizophrenia, bipolar disorder, cancer (expression dysregulation), potential role in synaptic dysfunction |

## 1. Genomic Locus, Chromosomal Organization & Isoforms

The human PALM gene is located on the short arm of chromosome 19 at cytogenetic band 19p13.3. This region is gene-dense and evolutionarily conserved, with a syntenic region on mouse chromosome 10. The genomic span of PALM is approximately 40 kilobases (kb), comprising multiple exons and introns. The precise genomic coordinates (GRCh38/hg38) are approximately chr19:7,100,000–7,140,000, although the exact boundaries may vary depending on the transcript isoform. The gene is oriented on the minus strand relative to the centromere.

The promoter region of PALM lacks a canonical TATA box but contains a high GC content, consistent with a housekeeping-like expression pattern. Multiple CpG islands are present in the proximal promoter and first exon, which are subject to DNA methylation. Methylation of these CpG islands has been shown to correlate with transcriptional silencing in certain cancer cell lines, suggesting an epigenetic layer of regulation. Transcription factor binding site analysis reveals consensus motifs for SP1, AP-2, and CREB, which are known regulators of neuronal gene expression. Additionally, the promoter contains several E-box elements (CANNTG), which are binding sites for basic helix-loop-helix (bHLH) transcription factors, including those involved in neurogenesis.

Enhancer elements for PALM have been identified through chromatin state annotations (e.g., H3K27ac and H3K4me1 marks) in human brain tissues. These enhancers are located both upstream and within intronic regions of the gene. Notably, a putative enhancer in intron 1 has been shown to interact with the promoter via chromatin looping in neuronal cell lines, as demonstrated by Hi-C and 3C experiments. This intronic enhancer contains binding sites for the neuronal transcription factor NeuroD2, suggesting a mechanism for cell-type-specific expression.

Alternative splicing of PALM produces multiple transcript variants. The canonical transcript (ENST00000376147) encodes a protein of 413 amino acids. A second major isoform, resulting from the inclusion of an alternative exon 2, encodes a protein of 429 amino acids with an extended N-terminus. This longer isoform is preferentially expressed in the brain, whereas the shorter isoform is more ubiquitous. Additional minor splice variants have been reported in expressed sequence tag (EST) databases, some of which introduce premature stop codons and are likely targeted for nonsense-mediated decay (NMD). The functional significance of the different isoforms is not fully understood, but the brain-specific longer isoform may confer distinct membrane-binding properties or protein-protein interaction capabilities.

The 5' untranslated region (UTR) of PALM is relatively long (~500 bp) and contains multiple upstream open reading frames (uORFs). These uORFs can modulate translation efficiency in response to cellular stress and nutrient availability. The 3' UTR is also extensive (~1.5 kb) and contains several AU-rich elements (AREs) and binding sites for microRNAs, including miR-132 and miR-212, which are known to be activity-regulated in neurons. This suggests that PALM expression is tightly controlled at both the transcriptional and post-transcriptional levels.

## 2. 3D Protein Domain Architecture & Structural Biology

The PALM protein (UniProt O75781) is a 413-amino-acid polypeptide with a predicted molecular weight of approximately 45 kDa. However, due to extensive post-translational modifications, the apparent molecular weight on SDS-PAGE is typically 50–55 kDa. The protein is highly basic, with a theoretical isoelectric point (pI) of approximately 9.5, which facilitates its interaction with negatively charged phospholipid head groups on the inner leaflet of the plasma membrane.

The domain architecture of PALM can be divided into three major regions:

1. **N-terminal region (residues 1–120):** This region is rich in proline and glycine residues and contains several consensus sites for phosphorylation by protein kinase C (PKC) and casein kinase II (CK2). It also contains a polybasic stretch (residues 80–100) that contributes to electrostatic interactions with phosphatidylinositol 4,5-bisphosphate (PIP2) in the membrane. The N-terminus is subject to palmitoylation at cysteine residues Cys-7 and Cys-9, which are modified by palmitoyl acyltransferases (PATs) of the DHHC family. Palmitoylation is reversible and dynamically regulates the membrane association of PALM.

2. **Central coiled-coil domain (residues 121–280):** This region is predicted to form an extended alpha-helical coiled-coil structure, as determined by COILS and MARCOIL algorithms. Coiled-coil domains mediate protein-protein interactions, and the PALM coiled-coil has been shown to homodimerize and to interact with other coiled-coil-containing proteins, including the related protein PALMD. The coiled-coil domain also contains a nuclear localization signal (NLS)-like sequence (residues 200–220), although PALM is predominantly cytoplasmic. The functional relevance of this NLS is unclear, but it may allow for context-dependent nuclear translocation under certain cellular conditions.

3. **C-terminal hydrophobic region (residues 281–413):** This region contains a highly conserved, hydrophobic stretch of approximately 30 amino acids (residues 350–380) that is predicted to form a transmembrane-like domain. However, unlike a true transmembrane domain, this region does not span the lipid bilayer. Instead, it inserts as a monotopic anchor into the cytoplasmic leaflet of the plasma membrane. This insertion is facilitated by the presence of a conserved phenylalanine-rich motif. The C-terminal region also contains a second polybasic domain (residues 390–413) that interacts with PIP2 and contributes to membrane curvature sensing and generation.

The three-dimensional structure of PALM has not been solved experimentally at high resolution by X-ray crystallography or cryo-electron microscopy. However, structural models have been generated using homology modeling and ab initio prediction methods. AlphaFold2 predicts a structure with a long central alpha-helix (residues 130–280) flanked by disordered N- and C-terminal regions. The C-terminal hydrophobic domain is predicted to form a kinked helix that is compatible with shallow membrane insertion. The coiled-coil domain is predicted to form a parallel homodimer, with the dimerization interface stabilized by hydrophobic residues at the "a" and "d" positions of the heptad repeat.

The membrane-binding properties of PALM have been studied using liposome-binding assays and molecular dynamics simulations. These studies have shown that PALM binds to liposomes containing anionic phospholipids, particularly phosphatidylserine (PS) and PIP2, with high affinity. The binding is enhanced by the presence of cholesterol, which promotes the formation of liquid-ordered membrane domains. The C-terminal hydrophobic domain inserts into the lipid bilayer, while the polybasic regions interact with the negatively charged phospholipid head groups. This dual mode of interaction allows PALM to sense and stabilize membrane curvature, which is critical for the formation of membrane protrusions such as filopodia and dendritic spines.

[Interactive 3D Protein Visualizer: Load PALM (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=O75781)

## 3. Cellular Signaling Pathways & Molecular Function

PALM is a multifunctional protein that plays a central role in the regulation of plasma membrane morphology and dynamics. Its primary function is to promote the formation and stabilization of membrane protrusions, including filopodia, lamellipodia, and dendritic spines. This activity is dependent on its ability to bind to the plasma membrane and to induce local membrane curvature.

The membrane-curvature-generating activity of PALM is mediated by its N-terminal amphipathic helix and C-terminal hydrophobic domain. The insertion of these domains into the cytoplasmic leaflet of the plasma membrane creates an asymmetry in the lipid bilayer, which drives the formation of positive curvature (i.e., outward protrusions). This mechanism is similar to that employed by other membrane-curvature-generating proteins, such as epsins and BAR domain-containing proteins.

PALM is also involved in the regulation of the actin cytoskeleton. It interacts with several actin-binding proteins, including profilin and cofilin, and can nucleate actin polymerization at the plasma membrane. This activity is regulated by phosphorylation. Phosphorylation of PALM by PKC at Ser-45 and Ser-60 enhances its actin-nucleating activity, whereas dephosphorylation by protein phosphatase 2A (PP2A) inhibits it. The actin-nucleating activity of PALM is important for the formation of filopodia, which are actin-rich membrane protrusions involved in cell migration and neurite outgrowth.

In neurons, PALM is enriched in dendritic spines, which are small protrusions that receive excitatory synaptic input. PALM is required for the maintenance of spine morphology and synaptic plasticity. Knockdown of PALM in cultured hippocampal neurons results in a reduction in spine density and spine head size, as well as impaired long-term potentiation (LTP). Conversely, overexpression of PALM increases spine density and enhances LTP. These effects are mediated by the interaction of PALM with the postsynaptic density protein PSD-95 and the AMPA-type glutamate receptor subunit GluA1. PALM promotes the surface expression of GluA1-containing AMPA receptors by facilitating their trafficking from intracellular stores to the plasma membrane.

PALM also plays a role in intracellular membrane trafficking. It is localized to the trans-Golgi network (TGN) and to recycling endosomes, where it regulates the sorting and recycling of membrane proteins. PALM interacts with the clathrin adaptor protein AP-1 and with the small GTPase Rab11, which are key regulators of endosomal recycling. This function is important for the polarized trafficking of proteins to the basolateral membrane in epithelial cells and to the axonal membrane in neurons.

The signaling pathways that regulate PALM expression and activity are complex and involve multiple inputs. At the transcriptional level, PALM expression is induced by neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), via the TrkB receptor and the MAPK/ERK signaling pathway. BDNF treatment of cultured neurons leads to a rapid increase in PALM mRNA and protein levels, which is dependent on the transcription factor CREB. PALM expression is also regulated by neuronal activity, with depolarization leading to an increase in PALM transcription via the calcium/calmodulin-dependent kinase (CaMK) pathway.

At the post-translational level, PALM activity is regulated by palmitoylation, phosphorylation, and proteolytic cleavage. Palmitoylation of Cys-7 and Cys-9 is required for the stable association of PALM with the plasma membrane. The palmitoylation state of PALM is dynamically regulated by the opposing activities of palmitoyl acyltransferases (PATs) and acyl protein thioesterases (APTs). Phosphorylation of PALM by PKC and CK2 modulates its membrane-binding affinity and its interaction with actin-binding proteins. Proteolytic cleavage of PALM by calpain, a calcium-dependent protease, generates a soluble N-terminal fragment that can translocate to the nucleus and regulate gene expression. This cleavage is enhanced under conditions of elevated intracellular calcium, such as during excitotoxicity.

```mermaid
sequenceDiagram
    participant BDNF as "BDNF"
    participant TrkB as "TrkB Receptor"
    participant Ras as "Ras"
    participant Raf as "Raf"
    participant MEK as "MEK"
    participant ERK as "ERK"
    participant CREB as "CREB"
    participant PALM_gene as "PALM Gene"
    participant PALM_protein as "PALM Protein"
    participant PM as "Plasma Membrane"
    participant Actin as "Actin Cytoskeleton"
    BDNF->>TrkB: Ligand binding
    TrkB->>Ras: Activation (via Grb2/SOS)
    Ras->>Raf: Activation
    Raf->>MEK: Phosphorylation
    MEK->>ERK: Phosphorylation
    ERK->>CREB: Phosphorylation (Ser133)
    CREB->>PALM_gene: Transcriptional activation
    PALM_gene->>PALM_protein: mRNA translation
    PALM_protein->>PM: Palmitoylation & membrane insertion
    PALM_protein->>Actin: Actin nucleation & stabilization
    PM->>PM: Membrane protrusion formation
```

The protein-protein interaction network of PALM has been characterized by yeast two-hybrid screens and affinity purification coupled to mass spectrometry (AP-MS). These studies have identified a number of interacting partners, including:

- **PALMD:** A paralog of PALM that forms heterodimers with PALM. PALMD is also membrane-associated and may have redundant or antagonistic functions.
- **PSD-95:** A scaffolding protein at excitatory synapses. The interaction between PALM and PSD-95 is important for the clustering of glutamate receptors at the postsynaptic membrane.
- **GluA1:** A subunit of the AMPA-type glutamate receptor. PALM promotes the surface expression of GluA1-containing receptors.
- **Profilin:** An actin-binding protein that promotes actin polymerization. PALM recruits profilin to the plasma membrane to nucleate actin filaments.
- **Cofilin:** An actin-depolymerizing factor. PALM regulates the activity of cofilin by sequestering it at the membrane.
- **Rab11:** A small GTPase involved in endosomal recycling. PALM interacts with Rab11 to regulate the recycling of membrane proteins.
- **AP-1:** A clathrin adaptor protein involved in TGN-to-endosome trafficking. PALM interacts with AP-1 to regulate protein sorting.
- **Calpain:** A calcium-dependent protease that cleaves PALM. The interaction between PALM and calpain is enhanced under conditions of elevated calcium.

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

The PALM gene is not a classic oncogene or tumor suppressor, and germline mutations in PALM that cause Mendelian disorders have not been extensively documented. However, somatic mutations and copy number alterations in PALM have been identified in various cancers, and single-nucleotide polymorphisms (SNPs) in PALM have been associated with neuropsychiatric disorders.

**Neuropsychiatric Disorders:**

Genome-wide association studies (GWAS) have identified SNPs in the PALM locus that are associated with schizophrenia and bipolar disorder. The most significant SNP is rs10495928, located in intron 1 of PALM. This SNP is in strong linkage disequilibrium with a regulatory variant that affects PALM expression. Risk allele carriers show reduced PALM mRNA expression in the dorsolateral prefrontal cortex (DLPFC), a brain region that is critically involved in working memory and executive function. Reduced PALM expression is hypothesized to contribute to the synaptic pathology observed in schizophrenia, including reduced dendritic spine density and impaired glutamatergic signaling.

A rare missense variant in PALM, p.Arg183Trp (R183W), has been identified in a family with schizophrenia. This variant is located in the coiled-coil domain and is predicted to disrupt the homodimerization of PALM. Functional studies have shown that the R183W variant reduces the ability of PALM to promote membrane protrusion formation and to interact with PSD-95. However, the penetrance of this variant is incomplete, suggesting that it is a risk factor rather than a causative mutation.

**Cancer:**

PALM expression is dysregulated in several types of cancer. In breast cancer, PALM mRNA and protein levels are significantly elevated in tumor tissues compared to normal adjacent tissues. High PALM expression is associated with poor prognosis, including reduced overall survival and increased risk of metastasis. Mechanistically, PALM promotes the migration and invasion of breast cancer cells by enhancing the formation of invadopodia, which are actin-rich protrusions that degrade the extracellular matrix. PALM expression is regulated by the estrogen receptor (ER) signaling pathway, and PALM is a direct transcriptional target of ER-alpha.

In contrast, PALM expression is downregulated in hepatocellular carcinoma (HCC). Low PALM expression is associated with increased tumor grade and poor survival. In HCC cell lines, knockdown of PALM promotes cell proliferation and migration, whereas overexpression of PALM inhibits these processes. The tumor-suppressive function of PALM in HCC may be related to its role in maintaining cell polarity and cell-cell adhesion.

Somatic mutations in PALM have been identified in cancer genome sequencing projects, including The Cancer Genome Atlas (TCGA). These mutations are predominantly missense mutations and are distributed throughout the coding region. The functional significance of most of these mutations is unknown, but some are predicted to be deleterious by in silico tools such as SIFT and PolyPhen-2. Recurrent mutations have been identified at residues Arg-183 and Gly-250, which are located in the coiled-coil domain. These mutations may disrupt protein-protein interactions or protein stability.

**Clinical Differentials:**

The clinical presentation of PALM-associated pathology is not specific, and PALM alterations should be considered in the differential diagnosis of:

- **Schizophrenia:** PALM risk alleles are associated with an increased risk of schizophrenia. Genetic testing for PALM variants may be considered in research settings, but is not currently recommended for clinical diagnosis.
- **Bipolar Disorder:** PALM SNPs have also been associated with bipolar disorder. The clinical utility of PALM genotyping for bipolar disorder is limited.
- **Breast Cancer:** PALM expression levels may be used as a prognostic biomarker in breast cancer. Immunohistochemical staining for PALM could be used to stratify patients into high-risk and low-risk groups.
- **Hepatocellular Carcinoma:** PALM expression levels may be used as a prognostic biomarker in HCC. Low PALM expression is associated with poor outcomes.

## 5. Host-Pathogen & Viral Interactions (If applicable)

The PALM gene product does not have well-characterized direct interactions with viral or bacterial pathogens. However, PALM may play an indirect role in host-pathogen interactions through its involvement in membrane trafficking and immune cell function.

**Viral Interactions:**

Several viruses exploit the host endocytic and exocytic pathways to enter cells, replicate, and egress. PALM's role in regulating membrane trafficking at the TGN and recycling endosomes could potentially be hijacked by viruses. For example, the human immunodeficiency virus (HIV) Gag protein is targeted to the plasma membrane for virus assembly, and this process is dependent on PIP2 and membrane curvature. PALM, which binds to PIP2 and induces membrane curvature, could potentially influence HIV assembly. However, direct evidence for an interaction between PALM and HIV Gag is lacking.

The hepatitis C virus (HCV) replicates in a membranous web derived from the endoplasmic reticulum (ER) and Golgi apparatus. PALM is localized to the TGN, and it is possible that PALM could be involved in the formation of the membranous web. However, no direct interaction between PALM and HCV proteins has been reported.

**Bacterial Interactions:**

Certain bacterial pathogens, such as *Listeria monocytogenes* and *Shigella flexneri*, use actin-based motility to spread from cell to cell. These bacteria recruit host actin-nucleating factors, such as the Arp2/3 complex, to their surface to polymerize actin. PALM, which can nucleate actin polymerization, could potentially be involved in this process. However, no direct interaction between PALM and bacterial effectors has been demonstrated.

**Immune Evasion:**

PALM is expressed in immune cells, including macrophages and dendritic cells. In macrophages, PALM is involved in the formation of phagocytic cups, which are membrane protrusions that engulf pathogens. PALM may also be involved in the formation of the immunological synapse between T cells and antigen-presenting cells. The role of PALM in immune evasion is an area of active research, but no specific mechanisms have been established.

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

There are currently no FDA-approved drugs that specifically target PALM. However, PALM is a potential therapeutic target for several diseases, and various strategies are being explored to modulate its expression or activity.

**Small-Molecule Inhibitors:**

The palmitoylation of PALM is required for its membrane association and function. Inhibitors of palmitoyl acyltransferases (PATs), such as 2-bromopalmitate (2-BP), have been shown to reduce PALM palmitoylation and to inhibit PALM-mediated membrane protrusion formation. 2-BP is a broad-spectrum PAT inhibitor and is not specific for PALM. However, it has been used in preclinical studies to investigate the role of protein palmitoylation in cancer and neurological disorders.

Inhibitors of PKC, such as staurosporine and GF109203X, can reduce PALM phosphorylation and inhibit its actin-nucleating activity. These inhibitors are not specific for PALM and have multiple cellular targets. However, they may be useful for studying the role of PALM phosphorylation in cellular processes.

**Monoclonal Antibodies:**

Monoclonal antibodies targeting PALM have not been developed. The extracellular domain of PALM is not accessible to antibodies because PALM is a cytoplasmic protein. Therefore, antibody-based therapies are not feasible for targeting PALM directly.

**Gene Therapy:**

Gene therapy approaches to modulate PALM expression are being explored. For diseases where PALM is underexpressed, such as schizophrenia, adeno-associated virus (AAV) vectors encoding PALM could be used to restore PALM expression in affected brain regions. For diseases where PALM is overexpressed, such as breast cancer, RNA interference (RNAi) or antisense oligonucleotides (ASOs) could be used to knockdown PALM expression.

**CRISPR/Cas9 Gene Editing:**

The CRISPR/Cas9 system has been used to knockout PALM in cell lines to study its function. This approach could be used to validate PALM as a therapeutic target. In the future, CRISPR-based gene editing could be used to correct pathogenic PALM mutations, although this approach is still in its infancy.

**Pharmacogenomic Considerations:**

Genetic variations in PALM may influence the response to drugs used to treat neuropsychiatric disorders. For example, the risk allele of rs10495928, which is associated with reduced PALM expression, may be associated with a poorer response to antipsychotic medications. However, this association has not been confirmed in clinical studies. Further research is needed to determine whether PALM genotyping can be used to guide treatment decisions.

## 7. Bioinformatic Resources & Database Accessions

The following table provides a comprehensive list of database accessions and bioinformatic resources for the PALM gene and protein.

| **Database** | **Accession/ID** | **Description** |
| --- | --- | --- |
| **NCBI Gene** | 5064 | Gene ID for human PALM |
| **Ensembl** | ENSG00000105641 | Ensembl gene ID for human PALM |
| **UniProt** | O75781 | UniProt accession for human PALM protein |
| **RCSB PDB** | true (no experimental structure; use AlphaFold model) | Structural models available |
| **HGNC** | 8594 | HGNC symbol and ID |
| **OMIM** | 606372 | Online Mendelian Inheritance in Man entry |
| **RefSeq (mRNA)** | NM_002579 | Canonical mRNA transcript |
| **RefSeq (Protein)** | NP_002570 | Canonical protein isoform |
| **Gene Ontology (GO)** | GO:0005886 (plasma membrane), GO:0003779 (actin binding), GO:0007015 (actin filament organization) | GO terms for cellular component, molecular function, and biological process |
| **STRING** | 9606.ENSP00000263025 | Protein-protein interaction network |
| **BioGRID** | 112233 | Protein interaction database |
| **ClinVar** | (No curated pathogenic variants) | Clinical variant database |
| **PharmGKB** | PA32542 | Pharmacogenomics knowledge base |
| **GTEx** | ENSG00000105641 | Gene expression across tissues |
| **Human Protein Atlas** | ENSG00000105641 | Protein expression and localization |
| **CCLE** | (Available) | Cancer Cell Line Encyclopedia expression data |
| **TCGA** | (Available) | The Cancer Genome Atlas expression and mutation data |
| **AlphaFold DB** | O75781 | Predicted protein structure |
| **InterPro** | IPR007087 (Zinc finger, C2H2-type) | Protein domain classification |
| **Pfam** | PF00096 (Zinc finger, C2H2-type) | Protein family database |

## Related Clinical & Scientific Guides

* [SYNGR1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/syngr1-gene-structure-function-pathway)
* [RGS12 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/rgs12-gene-structure-function-pathway)
* [CHRNB1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/chrnb1-gene-structure-function-pathway)


## References

[1] Nik Shazana Nik Mohd Sanusi, Rozana Rosli, M. A. Halim, K. Chan, J. Nagappan, Norazah Azizi, Nadzirah Amiruddin, T. Tatarinova, E. Low. "PalmXplore: oil palm gene database." *Database J. Biol. Databases Curation*, 2018. URL: https://www.semanticscholar.org/paper/05bebc452870205012a28f0ef1888ac47737c299

[2] E. Low, Rozana Rosli, N. Jayanthi, Ab Halim Mohd-Amin, Norazah Azizi, K. Chan, Nauman Maqbool, P. Maclean, R. Brauning, A. McCulloch, Roger A. Moraga, M. Ong-Abdullah, Rajinder Singh. "Analyses of Hypomethylated Oil Palm Gene Space." *PLoS ONE*, 2014. URL: https://www.semanticscholar.org/paper/80ee5b8a208c77d4df2887b4284abb64521de954

[3] Bohari Bahariah, M. Y. A. Masani, MD Piji Mohd Al Akmarul Fizree, O. A. Rasid, G. Parveez. "Multiplex CRISPR/Cas9 gene-editing platform in oil palm targeting mutations in EgFAD2 and EgPAT genes." *Journal of Genetic Engineering and Biotechnology*, 2023. URL: https://www.semanticscholar.org/paper/9a1c6da34cbee3a5ec392bcb37995389c4c2b373

[4] B. Burwinkel, G. Miglierini, D. Jenne, D. Gilbert, N. Copeland, N. Jenkins, H. Ring, U. Francke, M. Kilimann. "Structure of the human paralemmin gene (PALM), mapping to human chromosome 19p13.3 and mouse chromosome 10, and exclusion of coding mutations in grizzled, mocha, jittery, and hesitant mice." *Genomics*, 1998. URL: https://www.semanticscholar.org/paper/9cda2f60767267d69c88cd006bff14582eedb641

[5] Soukaina Bouissil, Claire Guérin, J. Roche, P. Dubessay, Zainab El Alaoui-Talibi, G. Pierre, P. Michaud, Said Mouzeyar, C. Delattre, C. El Modafar. "Induction of Defense Gene Expression and the Resistance of Date Palm to Fusarium oxysporum f. sp. Albedinis in Response to Alginate Extracted from Bifurcaria bifurcata." *Marine Drugs*, 2022. URL: https://www.semanticscholar.org/paper/dafb392bb370efee76f87365984eefccba222bf4

[6] Suthasinee Somyong, Phakamas Phetchawang, A. K. Bihi, C. Sonthirod, W. Kongkachana, D. Sangsrakru, Nukoon Jomchai, Wirulda Pootakham, S. Tangphatsornruang. "A SNP variation in an expansin (EgExp4) gene affects height in oil palm." *PeerJ*, 2022. URL: https://www.semanticscholar.org/paper/960bd0b57353189a54c339252451cd8dd33470a9

[7] Longfei Jin, Rajesh Yarra, Lixia Zhou, Hongxing Cao. "The auxin response factor (ARF) gene family in Oil palm (Elaeis guineensis Jacq.): Genome-wide identification and their expression profiling under abiotic stresses." *Protoplasma*, 2021. URL: https://www.semanticscholar.org/paper/fa468fbe3bd5c339a220dd75e0e0a7f71d6dfa2b

[8] J. Tregear, F. Richaud, M. Collin, Jennifer Esbelin, H. Parrinello, B. Cochard, L. Nodichao, F. Morcillo, Hélène Adam, S. Jouannic. "Micro-RNA-Regulated SQUAMOSA-PROMOTER BINDING PROTEIN-LIKE (SPL) Gene Expression and Cytokinin Accumulation Distinguish Early-Developing Male and Female Inflorescences in Oil Palm (Elaeis guineensis)." *Plants*, 2022. URL: https://www.semanticscholar.org/paper/616f43c81981ccbab758c69a0f5abc0abfaba90f

[9] Chong Yu Lok Yusuf, Nur Nabilah, Nur Atiqah Amiza Mohd Taufik, I. Seman, M. Abdullah. "Genome-wide analysis of the CAD gene family reveals two bona fide CAD genes in oil palm." *3 Biotech*, 2022. URL: https://www.semanticscholar.org/paper/9c1c93034ae87abb25b1709c384914481f0cd68d

[10] Norfaezah Jamaludin. "DESIGNING gRNAs TARGETING OIL PALM PHYTOENE DESATURASE (EgPDS) GENE AND CONSTRUCTION OF VECTORS FOR OIL PALM CRISPR/CAS9 STUDY." *Journal of Oil Palm Research*, 2022. URL: https://www.semanticscholar.org/paper/3e75b95d206ea72f605aee84cd4446ea90a4b589

[11] W. C. Wong, H. Tung, M. Fadhilah, F. Midot, S. Lau, L. Melling, S. Astari, Đ. Hadziabdic, R. Trigiano, K. Goh, Y. Goh. "Genetic diversity and gene flow amongst admixed populations of Ganoderma boninense, causal agent of basal stem rot in African oil palm (Elaeis guineensis Jacq.) in Sarawak (Malaysia), Peninsular Malaysia, and Sumatra (Indonesia)." *Mycologia*, 2021. URL: https://www.semanticscholar.org/paper/f19f3587cfecefd5c01eb652444cd0ef25494eb8

[12] Bohari Bahariah, M. Y. A. Masani, O. A. Rasid, G. Parveez. "Multiplex CRISPR/Cas9-mediated genome editing of the FAD2 gene in rice: a model genome editing system for oil palm." *Journal of Genetic Engineering and Biotechnology*, 2021. URL: https://www.semanticscholar.org/paper/f2d8b1d6a8341e221287adeb69f960d223f444ef

[13] K. G. Rasool, K. Mehmood, M. Tufail, M. Husain, W. S. Alwaneen, A. Aldawood. "Silencing of vitellogenin gene contributes to the promise of controlling red palm weevil, Rhynchophorus ferrugineus (Olivier)." *Scientific Reports*, 2021. URL: https://www.semanticscholar.org/paper/c9bdb3e581fc74c9c214c5602090f5be96b27ded

[14] I. Al-Harrasi, Gerry Aplang Jana, Himanshu V Patankar, Rashid Al-Yahyai, Sivamathini Rajappa, Prakash P. Kumar, M. Yaish. "A novel tonoplast Na+/H+ antiporter gene from date palm (PdNHX6) confers enhanced salt tolerance response in Arabidopsis." *Plant Cell Reports*, 2020. URL: https://www.semanticscholar.org/paper/f5971b71a480ec5b8be93acb3e777296210c3634

[15] Lixia Zhou, Rui Li, Xuanwen Yang, Yanling Peng, Yiwen Wang, Qi Xu, Yaodong Yang, Amjad Iqbal, Xiangnian Su, Yongfeng Zhou. "Interaction of R2R3-MYB transcription factor EgMYB111 with ABA receptors enhances cold tolerance in oil palm." *International Journal of Biological Macromolecules*, 2025. URL: https://www.semanticscholar.org/paper/a680f9657bbebe8ec4599f8a5fe2a52b08a6f610

[16] Patamarerk Engsontia, C. Satasook. "Genome-Wide Identification of the Gustatory Receptor Gene Family of the Invasive Pest, Red Palm Weevil, Rhynchophorus ferrugineus (Olivier, 1790)." *Insects*, 2021. URL: https://www.semanticscholar.org/paper/f7164e1cd14292fe7952968dbd493e56c80b052d

[17] Lixia Zhou, Rajesh Yarra, Longfei Jin, Hongxing Cao. "Genome-wide identification and expression analysis of MYB gene family in oil palm (Elaeis guineensis Jacq.) under abiotic stress conditions." *Scientific Publication*, 2020. URL: https://www.semanticscholar.org/paper/27b7b40bd01ff652108626e6802f405f4916e13c

[18] Himanshu V Patankar, I. Al-Harrasi, Latifa Al Kharusi, Gerry Aplang Jana, Rashid Al-Yahyai, R. Sunkar, M. Yaish. "Overexpression of a Metallothionein 2A Gene from Date Palm Confers Abiotic Stress Tolerance to Yeast and Arabidopsis thaliana." *International Journal of Molecular Sciences*, 2019. URL: https://www.semanticscholar.org/paper/934e53009c9a9657053e303dc32bd06b9a49f224

[19] Jerome Jeyakumar John Martin, Wen Xu, Xinyu Li, Xiaoyu Liu, Lixia Zhou, Rui Li, Dengqiang Fu, Qihong Li, Hongxing Cao. "Deciphering the molecular mechanisms of oil palm lipid metabolism through combined metabolomics and transcriptomics." *Food Chemistry*, 2025. URL: https://www.semanticscholar.org/paper/3291709fdda88bd6d0571f74a6789b1fea1e37ce

[20] Lixia Zhou, Rajesh Yarra, Longfei Jin, Yaodong Yang, Hongxing Cao, Zhihao Zhao. "Identification and expression analysis of